Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure

Objective To assess the impact of iterative changes in preoperative and postoperative biopsy techniques on the outcomes of men undergoing the precision prostatectomy procedure. Precision prostatectomy is a novel surgical treatment for prostate cancer that aims to maximally preserve erectogenic nerve...

Full description

Bibliographic Details
Main Authors: Akshay Sood, Wooju Jeong, Firas Abdollah, Mani Menon, Ralph Grauer, Michael A. Gorin, Mohit Butaney, Phil Olson, Guillaume Farah, Renee Hanna Cole
Format: Article
Language:English
Published: BMJ Publishing Group 2022-10-01
Series:BMJ Surgery, Interventions, & Health Technologies
Online Access:https://sit.bmj.com/content/4/1/e000122.full
_version_ 1797215253875916800
author Akshay Sood
Wooju Jeong
Firas Abdollah
Mani Menon
Ralph Grauer
Michael A. Gorin
Mohit Butaney
Phil Olson
Guillaume Farah
Renee Hanna Cole
author_facet Akshay Sood
Wooju Jeong
Firas Abdollah
Mani Menon
Ralph Grauer
Michael A. Gorin
Mohit Butaney
Phil Olson
Guillaume Farah
Renee Hanna Cole
author_sort Akshay Sood
collection DOAJ
description Objective To assess the impact of iterative changes in preoperative and postoperative biopsy techniques on the outcomes of men undergoing the precision prostatectomy procedure. Precision prostatectomy is a novel surgical treatment for prostate cancer that aims to maximally preserve erectogenic nerves via partial preservation of the prostate capsule.Design Retrospective.Setting Single tertiary care center.Participants This study included 120 patients who consented to undergo prostate cancer treatment with the precision prostatectomy procedure. Patients were originally enrolled in one of two separate prospective protocols studying precision prostatectomy.Interventions Preoperatively, 60 patients were screened with transrectal (TR) biopsy and 60 were screened by transperineal (TP) biopsy. Ultimately, 117 patients underwent precision prostatectomy. Of the 43 postoperative biopsies, 19 were TR; 17 were TP with ultrasound; and 7 were TP with microultrasound (mUS).Main outcome measures Preoperatively, we evaluated whether the transition to TP biopsy was associated with differences in postoperative treatment failure defined as a neoplasm-positive postoperative biopsy. Postoperative biopsies were compared with respect to their ability to sample the remnant tissue, specifically percentage of cores positive for prostate tissue.Results Preoperatively, 9/60 (15%) positive postoperative biopsies occurred in the TR group and 6/60 (10%) in the TP group; Kaplan-Meier survival estimates did not differ between groups (p=0.69 by log rank). Postoperatively, the numbers of cores positive for prostate tissue were 99/160 (62%), 63/107 (59%), and 36/39 (92%) in the TR biopsy, TP with ultrasound, and TP with mUS groups, respectively; this difference was statistically significant versus the rate in the TR and standard TP groups (p=0.0003 and 0.0002).Conclusion We found no significant improvement in patient screening, preoperatively—though limited by small sample size and relatively short follow-up. The incorporation of high-frequency mUS for postoperative biopsies improved the ability to sample the remnant tissue with a higher efficiency.
first_indexed 2024-04-24T11:27:08Z
format Article
id doaj.art-cda16d7274654c8ca8c4086c8048d411
institution Directory Open Access Journal
issn 2631-4940
language English
last_indexed 2024-04-24T11:27:08Z
publishDate 2022-10-01
publisher BMJ Publishing Group
record_format Article
series BMJ Surgery, Interventions, & Health Technologies
spelling doaj.art-cda16d7274654c8ca8c4086c8048d4112024-04-10T14:30:09ZengBMJ Publishing GroupBMJ Surgery, Interventions, & Health Technologies2631-49402022-10-014110.1136/bmjsit-2021-000122Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedureAkshay Sood0Wooju Jeong1Firas Abdollah2Mani Menon3Ralph Grauer4Michael A. Gorin5Mohit Butaney6Phil Olson7Guillaume Farah8Renee Hanna Cole9Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USAVattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USAVattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USADepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USADepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USAUrology, Urology Associates and UPMC Western Maryland, Cumberland, Maryland, USAVattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USAVattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USAVattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USAVattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USAObjective To assess the impact of iterative changes in preoperative and postoperative biopsy techniques on the outcomes of men undergoing the precision prostatectomy procedure. Precision prostatectomy is a novel surgical treatment for prostate cancer that aims to maximally preserve erectogenic nerves via partial preservation of the prostate capsule.Design Retrospective.Setting Single tertiary care center.Participants This study included 120 patients who consented to undergo prostate cancer treatment with the precision prostatectomy procedure. Patients were originally enrolled in one of two separate prospective protocols studying precision prostatectomy.Interventions Preoperatively, 60 patients were screened with transrectal (TR) biopsy and 60 were screened by transperineal (TP) biopsy. Ultimately, 117 patients underwent precision prostatectomy. Of the 43 postoperative biopsies, 19 were TR; 17 were TP with ultrasound; and 7 were TP with microultrasound (mUS).Main outcome measures Preoperatively, we evaluated whether the transition to TP biopsy was associated with differences in postoperative treatment failure defined as a neoplasm-positive postoperative biopsy. Postoperative biopsies were compared with respect to their ability to sample the remnant tissue, specifically percentage of cores positive for prostate tissue.Results Preoperatively, 9/60 (15%) positive postoperative biopsies occurred in the TR group and 6/60 (10%) in the TP group; Kaplan-Meier survival estimates did not differ between groups (p=0.69 by log rank). Postoperatively, the numbers of cores positive for prostate tissue were 99/160 (62%), 63/107 (59%), and 36/39 (92%) in the TR biopsy, TP with ultrasound, and TP with mUS groups, respectively; this difference was statistically significant versus the rate in the TR and standard TP groups (p=0.0003 and 0.0002).Conclusion We found no significant improvement in patient screening, preoperatively—though limited by small sample size and relatively short follow-up. The incorporation of high-frequency mUS for postoperative biopsies improved the ability to sample the remnant tissue with a higher efficiency.https://sit.bmj.com/content/4/1/e000122.full
spellingShingle Akshay Sood
Wooju Jeong
Firas Abdollah
Mani Menon
Ralph Grauer
Michael A. Gorin
Mohit Butaney
Phil Olson
Guillaume Farah
Renee Hanna Cole
Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
BMJ Surgery, Interventions, & Health Technologies
title Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
title_full Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
title_fullStr Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
title_full_unstemmed Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
title_short Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
title_sort impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure
url https://sit.bmj.com/content/4/1/e000122.full
work_keys_str_mv AT akshaysood impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT woojujeong impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT firasabdollah impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT manimenon impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT ralphgrauer impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT michaelagorin impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT mohitbutaney impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT philolson impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT guillaumefarah impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure
AT reneehannacole impactofprostatebiopsytechniqueonoutcomesoftheprecisionprostatectomyprocedure